Serum prolactin and macroprolactin in heart failure: No relation to established laboratory or clinical parameters

Annals of Clinical Biochemistry

Volumn 48, Issue 1, 2011, Pages 51-56

  Landberg, Eva ^a   Dahlström, Ulf ^a   Alehagen, Urban ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; MACROPROLACTIN; PROLACTIN; THYROTROPIN; UNCLASSIFIED DRUG;

AGED; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR DISEASE; CLINICAL EXAMINATION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; LABORATORY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SYMPTOM;

ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; HEART FAILURE; HUMANS; HYPERPROLACTINEMIA; MALE; MIDDLE AGED; PROGNOSIS; PROLACTIN; STATISTICS AS TOPIC; YOUNG ADULT;

EID: 79551476177     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/acb.2010.010164     Document Type: Article

References (31)

1. Goffin V, Binart N, Touraine P, Kelly PA. Prolactin: the new biology of an old hormone. Annu Rev Physiol 2002;64:47-67
2. Wallaschofski H, Kobsar A, Sokolova O, Eigenthaler M, Lohmann T. Co-activation of platelets by prolactin or leptin - pathophysiological findings and clinical implications. Horm Metab Res 2004;36:1-6 (Pubitemid 38283186)
3. Raaz D, Wallaschofski H, Stumpf C, et al. Increased prolactin in acute coronary syndromes as putative co-activator of ADP-stimulated P-selectin expression. Horm Metab Res 2006;38:767-72
4. Wallaschofski H, Donne M, Eigenthaler M, et al. PRL as a novel potent cofactor for platelet aggregation. J Clin Endocrinol Metab 2001;86:5912-19
5. De Lorenzo F, Saba N, Kakkar VV. Blood coagulation in patients with chronic heart failure: evidence for hypercoagulable state and potential for pharmacological intervention. Drugs 2003;63:565-76 (Pubitemid 36384622)
6. Alehagen U, Dahlstrom U, Lindahl TL. Elevated D-dimer level is an independent risk factor for cardiovascular death in out-patients with symptoms compatible with heart failure. Thromb Haemost 2004;92:1250-8 (Pubitemid 39642533)
7. Limas CJ, Kroupis C, Haidaroglou A, Cokkinos DV. Hyperprolactinaemia in patients with heart failure: clinical and immunogenetic correlations. Eur J Clin Invest 2002;32:74-8 (Pubitemid 36232726)
8. Opalinska-Ciszek E, Niemczyk S, Matuszkiewicz-Rowinska J. [Prolactin (PRL), thyrotropin (TSH), free thyroid hormones (fT4), (fT3) and testosterone (TTE) level in men with chronic heart failure]. Pol Arch Med Wewn 2005;113:320-5
9. Schneider W, Marcovitz S, Al-Shammari S, Yago S, Chevalier S. Reactivity of macroprolactin in common automated immunoassays. Clin Biochem 2001;34:469-73 (Pubitemid 33001316)
10. Hattori N. Macroprolactinemia: a new cause of hyperprolactinemia. J Pharmacol Sci 2003;92:171-7
11. Gibney J, Smith TP, McKenna TJ. Clinical relevance of macroprolactin. Clin Endocrinol (Oxf) 2005;62:633-43
12. Wallace IR, Satti N, Courtney CH, et al. Ten-year clinical follow-up of a cohort of 51 patients with macroprolactinemia establishes it as a benign variant. J Clin Endocrinol Metab 2010;95:3268-71
13. Fahie-Wilson MN, John R, Ellis AR. Macroprolactin; high molecular mass forms of circulating prolactin. Ann Clin Biochem 2005;42:175-92 (Pubitemid 40694957)
14. Alehagen U, Eriksson H, Nylander E, Dahlström U. Heart failure in the elderly. Characteristics of a Swedish primary health care population. Heart Drug 2002;2:211-20
15. Choy AM, Darbar D, Lang CC, et al. Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods. Br Heart J 1994;72:16-22
16. Jensen-Urstad K, Bouvier F, Hojer J, et al. Comparison of different echocardiographic methods with radionuclide imaging for measuring left ventricular ejection fraction during acute myocardial infarction treated by thrombolytic therapy. Am J Cardiol 1998;81:538-44 (Pubitemid 28182414)
17. van Royen N, Jaffe CC, Krumholz HM, et al. Comparison and reproducibility of visual echocardiographic and quantitative radionuclide left ventricular ejection fractions. Am J Cardiol 1996;77:843-50
18. Vekemans M, Robyn C. Influence of age on serum prolactin levels in women and men. Br Med J 1975;4:738-9
19. Olukoga AO, Kane JW. Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition. Clin Endocrinol (Oxf) 1999;51:119-26
20. Fahie-Wilson M, Brunsden P, Surrey J, Everitt A. Macroprolactin and the Roche Elecsys prolactin assay: characteristics of the reaction and detection by precipitation with polyethylene glycol. Clin Chem 2000;46:1993-5
21. Fruhwald FM, Fahrleitner A, Watzinger N, et al. Natriuretic peptides in patients with diastolic dysfunction due to idiopathic dilated cardiomyopathy. Eur Heart J 1999;20:1415-23
22. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008;10:933-89
23. McCormick SD, Bradshaw D. Hormonal control of salt and water balance in vertebrates. Gen Comp Endocrinol 2006;147:3-8
24. Ibarra F, Crambert S, Eklof AC, et al. Prolactin, a natriuretic hormone, interacting with the renal dopamine system. Kidney Int 2005;68:1700-7 (Pubitemid 43169914)
25. Wallaschofski H, Kobsar A, Koksch M, et al. Prolactin receptor signaling during platelet activation. Horm Metab Res 2003;35:228-35
26. Wallaschofski H, Lohmann T, Stumpf C, Daniel WG, Garlichs CD. Lack of relevant association between prolactin and immune responses in patients with chronic heart failure. Eur J Clin Invest 2003;33:1018; author reply 9
27. Berta L, Frairia R, Fortunati N, Fazzari A, Gaidano G. Smoking effects on the hormonal balance of fertile women. Horm Res 1992;37:45-8
28. Gossain VV, Sherma NK, Srivastava L, Michelakis AM, Rovner DR. Hormonal effects of smoking-II: Effects on plasma cortisol, growth hormone, and prolactin. Am J Med Sci 1986;291:325-7 (Pubitemid 17035503)
29. Bjoro T, Morkrid L, Wergeland R, et al. Frequency of hyperprolactinaemia due to large molecular weight prolactin (150-170 kD PRL). Scand J Clin Lab Invest 1995;55:139-47
30. Hattori N, Ishihara T, Saiki Y. Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers. Clin Endocrinol (Oxf ) 2009;71:702-8
31. Strachan MW, Teoh WL, Don-Wauchope AC, et al. Clinical and radiological features of patients with macroprolactinaemia. Clin Endocrinol (Oxf) 2003;59:339-46